本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Iovance Biotherapeutics, Inc.

2.23
+0.290014.95%
盘后2.230.00000.00%19:57 EDT
成交量:2,465.12万
成交额:5,189.08万
市值:7.45亿
市盈率:-1.81
高:2.25
开:1.93
低:1.92
收:1.94
数据加载中...
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/09/20

SEC问询函

[Cover]Correspondence
2019/09/17

SEC问询函

[Cover]Correspondence
2019/08/01

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/01

重要事件披露

Current report, items 2.02 and 9.01
2019/07/19

持股变动声明

Initial statement of beneficial ownership of securities
2019/07/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/02

重要事件披露

Current report, items 8.01 and 9.01
2019/06/21

重要事件披露

Current report, items 1.01 and 9.01
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities